---
title: Self-management in Patients With Adrenal Insufficiency.
nct_id: NCT06637722
overall_status: ACTIVE_NOT_RECRUITING
sponsor: Region Stockholm
study_type: OBSERVATIONAL
primary_condition: Adrenal Insufficiency
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT06637722.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06637722"
ct_last_update_post_date: 2024-10-15
last_seen_at: "2026-05-12T06:23:38.085Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Self-management in Patients With Adrenal Insufficiency.

**NCT ID:** [NCT06637722](https://clinicaltrials.gov/study/NCT06637722)

## Key Facts

- **Status:** ACTIVE_NOT_RECRUITING
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 450
- **Lead Sponsor:** Region Stockholm
- **Conditions:** Adrenal Insufficiency
- **Start Date:** 2015-09
- **Completion Date:** 2025-03
- **CT.gov Last Update:** 2024-10-15

## Brief Summary

Background: Cortisol deficiency leads to a wide range of clinical consequences. Substitution with glucocorticoids is necessary and demands knowledge and ability to self-management from the patient.

Methods: Longitudinal questionnaire-based observational study including group education.

Research questions: To find out if education in group, enhances patients´ and relatives' knowledge about adequate dose adjustment of cortisone and increases the feeling of safety and QoL in patients with adrenal insufficiency.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

Adrenal insufficiency or relative to a person with adrenal insufficiency

Exclusion Criteria:

\-
```

## Arms

- **Patients with adrenal insufficiency and their relatives**

## Primary Outcomes

- **Questionnaire** _(time frame: 6 months)_ — Rate of participants responding accurately regarding stree-dosing in hypothetical situation of different degrees of physical and psychological stress.

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT06637722.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT06637722*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*